Abstract
Objective: We present an interesting case of accidental overdose of latanoprost eye drops.
Case Report: A 71-year-old patient underwent an uncomplicated cataract surgery in his right eye. During the first postsurgical week he mistakenly used latanoprost eye drops six times daily instead of the prescribed tobramycin/dexamethasone eye drops. The patient experienced gradually decreasing visual acuity and was diagnosed with cystoid macular edema seven weeks after surgery. The cystoid macular edema resolved 4 weeks later after treatment with nepafenac 0.3% eye drops and oral acetazolamide. The cystoid macular edema recurred 2 weeks after rechallenge with latanoprost. The rechallenge-induced cystoid macular edema once again resolved after cessation of latanoprost and retreatment with nepafenac eye drops. A Naranjo assessment score of 7 was obtained, indicating a probable relationship between the patient’s symptoms and the suspect drug.
Keywords: Cystoid macular edema, uneventful phacoemulsification, latanoprost overdose, rechallenge, prostaglandin analogues, best corrected visual acuity, optical coherence tomography.
Graphical Abstract
Current Drug Safety
Title:Cystoid Macular Edema Due to Accidental Latanoprost Overdose After Uncomplicated Phacoemulsification
Volume: 13 Issue: 3
Author(s): Olga E. Makri, Iasonas K. Tsekouras, Panagiotis Plotas, Foteini Tsapardoni, Athina Pallikari and Constantine D. Georgakopoulos*
Affiliation:
- Department of Ophthalmology, Medical School, University of Patras, Patras,Greece
Keywords: Cystoid macular edema, uneventful phacoemulsification, latanoprost overdose, rechallenge, prostaglandin analogues, best corrected visual acuity, optical coherence tomography.
Abstract: Objective: We present an interesting case of accidental overdose of latanoprost eye drops.
Case Report: A 71-year-old patient underwent an uncomplicated cataract surgery in his right eye. During the first postsurgical week he mistakenly used latanoprost eye drops six times daily instead of the prescribed tobramycin/dexamethasone eye drops. The patient experienced gradually decreasing visual acuity and was diagnosed with cystoid macular edema seven weeks after surgery. The cystoid macular edema resolved 4 weeks later after treatment with nepafenac 0.3% eye drops and oral acetazolamide. The cystoid macular edema recurred 2 weeks after rechallenge with latanoprost. The rechallenge-induced cystoid macular edema once again resolved after cessation of latanoprost and retreatment with nepafenac eye drops. A Naranjo assessment score of 7 was obtained, indicating a probable relationship between the patient’s symptoms and the suspect drug.
Export Options
About this article
Cite this article as:
Makri E. Olga , Tsekouras K. Iasonas , Plotas Panagiotis , Tsapardoni Foteini , Pallikari Athina and Georgakopoulos D. Constantine *, Cystoid Macular Edema Due to Accidental Latanoprost Overdose After Uncomplicated Phacoemulsification, Current Drug Safety 2018; 13 (3) . https://dx.doi.org/10.2174/1574886313666180619163845
DOI https://dx.doi.org/10.2174/1574886313666180619163845 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
In-silico & In-vitro Identification of Structure-Activity Relationship Pattern of Serpentine & Gallic Acid Targeting PI3Kγ as Potential Anticancer Target
Current Cancer Drug Targets The Anterior Gradient-2 Pathway as a Model for Developing Peptide-Aptamer Anti-Cancer Drug Leads that Stimulate p53 Function
Current Chemical Biology Mechanisms of Resistance to Photodynamic Therapy
Current Medicinal Chemistry Cationic Lipid-DNA Complexes for Gene Therapy: Understanding the Relationship Between Complex Structure and Gene Delivery Pathways at the Molecular Level
Current Medicinal Chemistry Meet Our Editorial Board Member
Current Nanoscience Structure and Function of the Type III Secretion System of Pseudomonas aeruginosa
Current Protein & Peptide Science Nanoparticle Drug Delivery Systems: Recent Patents and Applications in Nanomedicine
Recent Patents on Nanomedicine Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ Recipients
Current Drug Targets G Protein-Coupled Receptor Kinase 2 - a Feedback Regulator of Gq Pathway Signalling
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Oxidative Stress Mediated Mitochondrial and Vascular Lesions as Markers in the Pathogenesis of Alzheimer Disease
Current Medicinal Chemistry Herpes Simplex Encephalitis: From Virus to Therapy
Infectious Disorders - Drug Targets Unique Structural Motif Supports Mannosylphospho Dolichol Synthase: An Important Angiogenesis Regulator
Current Drug Targets Treatment with Paracetamol is not Associated with Increased Airway Sensitivity and Risk of Asthma in Rats
Current Drug Safety Nucleic-Acid Delivery Using Lipid Nanocapsules
Current Pharmaceutical Biotechnology Recent Patents on Metalloproteinases as Biomarkers in Osteoarthritis Diagnosis and Treatment
Recent Patents on Biomarkers Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy
Current Pharmaceutical Design Nuciferine Inhibits Skin Cutaneous Melanoma Cell Growth by Suppressing TLR4/NF-κB Signaling
Anti-Cancer Agents in Medicinal Chemistry Sirolimus: A Novel Immunosuppressive Drug in Heart Transplantation
Recent Patents on Cardiovascular Drug Discovery Neuroprotective Effects of Cannabidiol in Hypoxic Ischemic Insult. The Therapeutic Window in Newborn Mice
CNS & Neurological Disorders - Drug Targets Structure, Function and Inhibition of Bcl-2 Family Proteins: A New Target for Anti-Tumor Agents
Mini-Reviews in Medicinal Chemistry